Digital Guide: Next-Generation Sequencing for Breast Cancer
Johns Hopkins Kimmel Cancer Center's Dr. Jessica Tao breaks down how next-generation sequencing can be used to help find the best breast cancer treatment.
Next-generation sequencing (NGS), a type of molecular testing, can help you and your doctor decide on the best course of breast cancer treatment by identifying mutations in cancer cells that can be targeted.
Dr. Jessica Tao, a breast medical oncologist at Johns Hopkins Kimmel Cancer Center, explains when this particular type of testing may be helpful, particularly with more advanced disease, and what other tests women should expect (or ask for) after a diagnosis.
Your Digital Guide begins below: 4 Chapters / 4 Video Segments
Dr. Jessica Tao
Johns Hopkins
Several tests can help characterize breast cancer and guide treatment options. Testing the tumor for DNA mutations is done in metastatic disease as tumor-based mutations, like the common PIK3CA mutation, can be a target for new treatments.
